Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF93 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZRANB3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | ZSCAN29 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | ZSCAN5A | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | ZSCAN5B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ZSWIM5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |